# Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparison-of-tenofovir-i-versus-i-entecavir-on-reducing-incidence-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lihu Gu,Qigu Yao,Zefeng Shen,Ying He,Derry Minyao Ng,Tong Yang,Bangsheng Chen,Ping Chen,Feiyan Mao,Qili Yu |
| Citations | 39 |
| DOI | 10.1111/jgh.15036 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3010876076 |
| PMID | 32180249 |
| Type | review |
| Year | 2020 |

## Paper authors

- [Ying He](https://scholariq.org/researchers/ying-he/)
- [Bangsheng Chen](https://scholariq.org/researchers/bangsheng-chen/)

## Paper journal

- [Journal of Gastroenterology and Hepatology](https://scholariq.org/journals/journal-of-gastroenterology-and-hepatology/)

## Paper primary topic

- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)

## Paper topics

- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.